Red cell metabolism. A. Defects not causing hemolytic disease. B. Environmental modification.
D002374:Catalase / Q000097:blood; D002802:Cholinesterases / Q000097:blood; D004796:Clinical Enzyme Tests; D004912:Erythrocytes / Q000201:enzymology*; D005182:Flavin-Adenine Dinucleotide / Q000627:therapeutic use; D005693:Galactosemias; D005955:Glucosephosphate Dehydrogenase Deficiency; D005980:Glutathione Reductase / Q000097:blood; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D007926:Lesch-Nyhan Syndrome; D008661:Metabolism, Inborn Errors / Q000188:drug therapy; D009243:NAD / Q000627:therapeutic use; D009249:NADP / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000627:therapeutic use; D011736:Pyridoxine / Q000627:therapeutic use; D012256:Riboflavin / Q000627:therapeutic use
D009539:Nicotinic Acids; D009243:NAD; D005182:Flavin-Adenine Dinucleotide; D009249:NADP; D007770:L-Lactate Dehydrogenase; D002374:Catalase; D005980:Glutathione Reductase; D002802:Cholinesterases; D011736:Pyridoxine; D012256:Riboflavin